Skip to content
My WebMD Sign In, Sign Up

Cancer Health Center

Font Size

Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Options for Childhood Acute Lymphoblastic Leukemia

A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your child's doctor for clinical trials that are not listed here but may be right for your child.

Newly Diagnosed Childhood Acute Lymphoblastic Leukemia (Standard Risk)

Recommended Related to Cancer

Treatment for Monoclonal Gammopathy of Undetermined Significance

Standard Treatment Options for Monoclonal Gammopathy of Undetermined Significance (MGUS) Standard treatment options for MGUS include the following: Watchful waiting. Watchful waiting Multiple myeloma, other plasma cell dyscrasia, or lymphoma will develop in 12% of patients by 10 years, 25% by 20 years, and 30% by 25 years. All patients with MGUS should be kept under observation to detect increases in M protein levels and development of a plasma cell dyscrasia. Higher levels...

Read the Treatment for Monoclonal Gammopathy of Undetermined Significance article > >

Treatment of standard-risk childhood acute lymphoblastic leukemia (ALL) during the induction, consolidation /intensification, and maintenance phases may include the following:

  • Combination chemotherapy.
  • Combination chemotherapy followed by stem cell transplant using stem cells from a donor.
  • A clinical trial of a new chemotherapy regimen.
  • A clinical trial of a new combination chemotherapy and intrathecal chemotherapy regimen given with or without radiation therapy and/or stem cell transplant. The chemotherapy dose and/or schedule depends on the patient's risk group after induction therapy.

CNS-directed therapy to treat or prevent the spread of leukemia cells to the brain and spinal cord may include the following:

  • Intrathecal chemotherapy.
  • High-dose systemic chemotherapy.
  • Radiation therapy.
  • A clinical trial of a new anticancer drug, the doses of certain anticancer drugs, and the use of radiation therapy to the brain.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with untreated childhood acute lymphoblastic leukemia. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Newly Diagnosed Childhood Acute Lymphoblastic Leukemia (High Risk)

T-cell childhood acute lymphoblastic leukemia

Treatment of T-cell childhood acute lymphoblastic leukemia (ALL) may include the following:

  • Combination chemotherapy.
  • A clinical trial of a new chemotherapy regimen.

CNS-directed therapy to treat or prevent the spread of leukemia cells to the brain and spinal cord may include the following:

  • Intrathecal chemotherapy.
  • High-dose systemic chemotherapy.
  • Radiation therapy.
  • A clinical trial of a new anticancer drug, the doses of certain anticancer drugs, and the use of radiation therapy to the brain.

Infants with ALL

Treatment of infants with ALL may include the following:

  • Combination chemotherapy.
  • Chemotherapy followed by a donor stem cell transplant has been studied but it is not clear if this treatment improves survival.
  • A clinical trial of chemotherapy followed by a donor stem cell transplant for infants with certain gene changes.
  • A clinical trial of combination chemotherapy and targeted therapy with a tyrosine kinase inhibitor.

CNS-directed therapy to treat or prevent the spread of leukemia cells to the brain and spinal cord may include the following:

  • Intrathecal chemotherapy.
  • High-dose systemic chemotherapy.

Children and teenagers with ALL

Treatment of ALL in children and teenagers (10 years and older) may include the following:

  • Combination chemotherapy.
  • A clinical trial of a new combination chemotherapy regimen.
  • A clinical trial of a new anticancer drug, new doses of certain anticancer drugs, and the use of radiation therapy to the brain. The chemotherapy dose and/or schedule depends on the patient's risk group after induction therapy.
1|2

WebMD Public Information from the National Cancer Institute

Last Updated: February 25, 2014
Next Article:

Today on WebMD

Building a Support System
Blog
cancer fighting foods
SLIDESHOW
 
precancerous lesions slideshow
SLIDESHOW
quit smoking tips
SLIDESHOW
 
Jennifer Goodman Linn self-portrait
Blog
what is your cancer risk
HEALTH CHECK
 
colorectal cancer treatment advances
Video
breast cancer overview slideshow
SLIDESHOW
 
prostate cancer overview
SLIDESHOW
lung cancer overview slideshow
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
Actor Michael Douglas
Article